Exoskeleton-Assisted Movement for Stroke
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking medications that influence brain function, you may not be eligible to participate.
What data supports the effectiveness of the treatment Real-time Neuromuscular Control of Exoskeletons for stroke patients?
Research shows that exoskeletons can help stroke patients improve their walking and arm movements by providing support and assistance. Studies have found that these devices can safely aid in movement without causing stress or pain, and they can help therapists identify and address muscle weaknesses and coordination issues.12345
Is exoskeleton-assisted movement safe for stroke rehabilitation?
How does the Real-time Neuromuscular Control of Exoskeletons treatment differ from other stroke treatments?
This treatment is unique because it uses real-time neuromuscular control to assist movement, relying on the patient's own muscle signals to guide the exoskeleton. This approach enhances the patient's active participation in rehabilitation, unlike traditional therapies that may not integrate real-time feedback from muscle activity.458910
What is the purpose of this trial?
The purpose of this study is to develop a real-time controller for exoskeletons using neural information embedded in human musculature. This controller will consist of an online interface that anticipates human movement based on high-density electromyography (HD-EMG) recordings, and then translates it into functional assistance. This study will be carried out in both healthy participants and participants post-stroke.The researchers will develop an online algorithm (decoder) in currently existing exoskeletons that can extract hundreds of motor unit (MU) spiking activity out of HD-EMG recordings. The MU spiking activity is a train of action potentials coded by its timing of occurrence that gives access to a representative part of the neural code of human movement. The researchers will also develop a command encoder that can anticipate human intent (multi-joint position and force commands) from MU spiking activity to translate the neural information to movement. The researchers will integrate the decoder with the command encoder to showcase the real-time control of multiple joint lower-limb exoskeletons.
Research Team
Jose Pons, Ph.D
Principal Investigator
Shirley Ryan AbilityLab
Eligibility Criteria
This trial is for adults aged 18-80 with normal movement in their limbs, no brain/skull lesions, correctable hearing and vision. It includes stroke survivors who had a unilateral, supratentorial stroke over 6 months ago without other neurological disorders.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experiment A
Muscle activity data collection via HD-EMG from healthy and post-stroke participants during single-joint and locomotor tasks
Experiment B
Calibration and real-time assistance with exoskeleton for healthy and post-stroke participants, including multiple sessions to evaluate decoder stability
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Real-time Neuromuscular Control of Exoskeletons
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor